NRXS
Price:
$6.7
Market Cap:
$82.98M
NeurAxis, Inc. (NRXS) is an American company specializing in neuromodulation therapy devices. Its primary offering is IB-Stim, a percutaneous electrical nerve field stimulation system engineered to alleviate functional abdominal pain associated with irritable bowel syndrome in patients aged 11 to 18. NeurAxis markets its solutions to healthcare providers, predominantly hospitals and clinics. The firm, headquartered in Carmel, Indiana, was established in 2011 and operated as Innovative Health Solutions, Inc. until its rebranding to NeurAxis, Inc. in March 2022.
Industry
Biotechnology
IPO Date
2023-08-09
Stock Exchange
AMEX
Ticker
NRXS
According to NeurAxis, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 2.89. This represents a change of 23.77% compared to the average of 2.34 of the last 4 quarters.
The mean historical Current Ratio of NeurAxis, Inc. over the last ten years is 1.13. The current 2.89 Current Ratio has changed 25.47% with respect to the historical average. Over the past ten years (40 quarters), NRXS's Current Ratio was at its highest in in the March 2026 quarter at 2.89. The Current Ratio was at its lowest in in the March 2022 quarter at 0.
Average
1.13
Median
1.05
Minimum
0.07
Maximum
2.44
Discovering the peaks and valleys of NeurAxis, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.26%
Maximum Annual Current Ratio = 2.44
Minimum Annual Increase = -85.88%
Minimum Annual Current Ratio = 0.07
| Year | Current Ratio | Change |
|---|---|---|
| 2025 | 2.05 | 17.12% |
| 2024 | 1.75 | 1.26% |
| 2023 | 0.13 | 88.23% |
| 2022 | 0.07 | -80.17% |
| 2021 | 0.34 | -85.88% |
The current Current Ratio of NeurAxis, Inc. (NRXS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
1.31
5-year avg
0.87
10-year avg
1.13
NeurAxis, Inc.’s Current Ratio is greater than CollPlant Biotechnologies Ltd. (2.27), greater than NeuroSense Therapeutics Ltd. (0.31), greater than Exicure, Inc. (0.79), less than Klotho Neurosciences, Inc. (95.01), less than Enlivex Therapeutics Ltd. (193.24), greater than Cadrenal Therapeutics, Inc. Common Stock (2.68), less than Sonnet BioTherapeutics Holdings, Inc. (3.50), less than Minerva Neurosciences, Inc. (17.65), less than TAO Synergies Inc. (27.40), less than Rallybio Corporation (12.92),
| Company | Current Ratio | Market cap |
|---|---|---|
| 2.27 | $4.14M | |
| 0.31 | $18.13M | |
| 0.79 | $17.72M | |
| 95.01 | $20.08M | |
| 193.24 | $16.29M | |
| 2.68 | $10.61M | |
| 3.50 | $8.43M | |
| 17.65 | $31.54M | |
| 27.40 | $11.90M | |
| 12.92 | $84.35M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like NeurAxis, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like NeurAxis, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is NeurAxis, Inc.'s Current Ratio?
How is the Current Ratio calculated for NeurAxis, Inc. (NRXS)?
What is the highest Current Ratio for NeurAxis, Inc. (NRXS)?
What is the 3-year average Current Ratio for NeurAxis, Inc. (NRXS)?
What is the 5-year average Current Ratio for NeurAxis, Inc. (NRXS)?
How does the current Current Ratio for NeurAxis, Inc. (NRXS) compare to its historical average?